Navigation Links
Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients
Date:11/17/2010

protective therapies for the treatment of cardiovascular diseases - today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.

Forty-five patients with severe heart failure of ischemic origin participated in the C-Cure multicenter Clinical Trial in Belgium, Serbia and Switzerland, and were randomized to optimal standard of care (control group; n=24) or optimal standard of care plus C-Cure treatment (treatment group; n=21). The primary objective of this trial was to assess the safety and feasibility of C-Cure, a stem cell product candidate derived from the patient's own bone marrow and guided to cardiac lineage cells.

Beyond meeting the safety objective as assessed by an independent safety board, the trial revealed that six months after receiving C-Cure, patients in the treatment group showed significant improvements in a number of measures of their heart function.

Patients receiving the trial drug C-Cure saw an 18.1% increase in left ventricular ejection fraction (LVEF) over baseline at the six month follow-up point, as measured by echocardiography, while the mean LVEF increased only by 3.6% in patients enrolled in the control group. This difference in LVEF between the C-Cure treated and control patients was highly significant (p<0.0001).

The trial also generated data that suggest favorable remodelling of heart muscle and improved heart muscle performance in the treatment versus control group. Signs of functional improvement were supported by improved fitness, shown by a significant mean difference in the 6-minute walking distance test between the treatment and control groups.

In terms of feasibility, the bone marrow of 70% of the attempted 30 patients was successfully processed into C-Cure. The company is targeting even fur
'/>"/>

SOURCE Cardio3 BioSciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Award Winning Mayo Clinic Scientist Joins Cardio3 BioSciences
2. Cardio3 BioSciences Announces Promising Pre-Clinical Data for Proprietary C-Cath(R) Catheter
3. Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
4. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
5. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
6. Magellan Biosciences to Debut Revolutionary New Dynex® Clinical Diagnostics Processing System for Fully Automated ELISA Testing at MEDICA 2010
7. Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference
8. Ambit Biosciences Strengthens Board of Directors and Executive Team
9. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
10. Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
11. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 PuraMed BioScience®, Inc., (OTC Pink: PMBS), ... and healthcare products, announced it received the initial funding ... advanced headache relief product, for planned distribution to 1,000 ... , Washington State , and ... MigraPure H Advanced headache relief gel formulation completed, PuraMed ...
(Date:12/24/2014)... KENNEWICK, Wash. , Dec. 23, 2014 /PRNewswire/ ... stage development company engaged primarily in the development ... and therapeutic applications, today announced that it has ... the Food and Drug Administration ("FDA") for marketing ... to Section 513(f)(2) of the U.S. Food, Drug ...
(Date:12/24/2014)... December 24, 2014 ... Global Disposable Syringe Industry of 178 pages ... business intelligence library. The 2014 ... Industry is a professional and deep research ... overview analysis, the report introduces Disposable Syringe ...
Breaking Medicine Technology:PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... Calif., Dec. 7, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... the company,s president and chief operating officer, is scheduled ... Annual Healthcare Conference in New York City on Wednesday, ... (Logo: http://photos.prnewswire.com/prnh/20030226/RIGLLOGO ) To ...
... 7, 2011   Talyst has released an updated ... The bar code technology ensures virtually 100% of medications ... The improved AutoLabel is a complete ... and white transfer labels to improve patient safety at ...
Cached Medicine Technology:Talyst Updates Its AutoLabel® Solution 2
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast ... treatment landscape, unmet needs, current pipeline and commercial opportunities ... drug which is typically used for treating colorectal cancer. ... treating gastric cancer and pancreatic cancer. TS-1 is composed ... first approved in 1999 in Japan for the treatment ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses and ... of black one-shoulder cocktail dresses . In addition, all ... at discounted prices, up to 70% off. , ... weeks only. You know, we have thousands of frequent callers ... new items can visit our website for more details. The ...
(Date:12/25/2014)... BellasDress has launched its Christmas Sale, offering ... chosen their best-selling lace wedding dresses, vintage bridesmaid dresses ... , Now, BellasDress.com features popular women’s dresses, and ... prices. The business hopes everyone can have a memorable ... “All our elegant products are made with exquisite materials; ...
(Date:12/25/2014)... When head lice hits a home or school, parents ... rid of it while keeping it from taking over the ... the solution right in their neighborhood: Lice Troopers . ... full spectrum head lice screening and treatment services to families ... Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , ...
(Date:12/25/2014)... News) -- The risk of burns from fires and ... to be extra cautious, an expert says. "Between ... increase in patients coming in with burns," said Dr. ... Firefighters Burn Center of Stony Brook University Hospital in ... joy, but if not careful, could quickly turn tragic," ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2
... sickle cell disease who also have lower blood oxygen ... have heart abnormalities, researchers at Washington University School of ... Heart problems are fairly common in young adults ... why. The researchers demonstrated that lower oxygen saturation in ...
... ... (radial Keratotomy) may benifit from PRELEX with crystalens according to Dr. Khanna. , ... (Vocus) April 27, 2010 -- Patents that ... Khanna. Radial Keratotomy was in vogue in the late seventy’s and eighties. Its popularity declined ...
... function , TUESDAY, April 27 (HealthDay News) -- High-dose ... and patients on this regimen should stop immediately, says a ... believed it would show that high-dose vitamin B therapy (folic ... function and reduce their risk of heart attack and stroke. ...
... study finds problems contracting, relaxing, , TUESDAY, April 27 ... the heart more than had been thought, a new ... what might be the first clear evidence that these ... damage heart function, said Dr. Aaron L. Baggish, an ...
... Digestive Health and Nutrition (FDHN) announced this year,s recipient ... Kenneth P. Olive, PhD. The $225,000 gift from ... with funding and protected time for three years to ... Schwartz, a businessman and photographer, suffered from the disease ...
... ... to select their perfect retirement community based on community culture, personality, amenities and personal preferences. ... Princeton, NJ (PRWEB) ... can be a complicated, confusing chore. In fact, retirees and their families must choose ...
Cached Medicine News:Health News:Low blood oxygen may lead to heart defects in children with sickle cell disease 2Health News:Low blood oxygen may lead to heart defects in children with sickle cell disease 3Health News:Crystalens HD May Help People with RK 2Health News:Steroids Could Harm Heart's Pumping Ability 2Health News:Steroids Could Harm Heart's Pumping Ability 3Health News:Second AGA Foundation/Bernard Lee Schwartz Foundation Research Scholar Award presented 2Health News:RetiringbyDesign.com Offers Retirees a Smarter Way to Explore Living Options 2Health News:RetiringbyDesign.com Offers Retirees a Smarter Way to Explore Living Options 3
Each Uro-Safe® vinyl leg bag is hand-tested for defects through each phase of the manufacturing process and packaged individually in a sterile, easy, peel-open pouch with two latex leg straps....
... This remarkable anti-reflux valve ... plastic housing which prevents the ... closed when in sitting or ... virtually self-cleaning and interference free ...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
Medicine Products: